SEC Tracker
Get the app

Mirum Pharmaceuticals MIRM

Christopher Peetz (MIRM) reports insider transactions.

Christopher Peetz, insider filing for MIRM

Form
4
Filed
Importance
Routine
  1. Christopher Peetz, CEO, bought 5,305 shares at $19.19.
  2. Peetz bought 6,892 shares at $15.87.
  3. Peetz holds 199,745 shares directly.
  4. Peetz holds 187,500 shares indirectly via trust.

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Mirum Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Acadia Pharmaceuticals ACAD public float $2.3B, Jun 30, 2025
  2. Twist Bioscience TWST public float $2.3B, Mar 31, 2025, over 18 months old
  3. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025
  4. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  5. Cytokinetics CYTK public float $2.5B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.